"10.1371_journal.pone.0126370","plos one","2015-07-01T00:00:00Z","Nilminie Rathnayake; Anders Gustafsson; Anna Norhammar; Barbro Kjellström; Björn Klinge; Lars Rydén; Taina Tervahartiala; Timo Sorsa; PAROKRANK Steering Group","Karolinska Institutet, Department of Dental Medicine, Division of Periodontology, Stockholm, Sweden; Karolinska Institutet, Karolinska University Hospital Solna, Department of Medicine, Cardiology Unit, Stockholm, Sweden; University of Helsinki, Helsinki University Central Hospital, Department of Oral and Maxillofacial Diseases, Helsinki, Finland; University of Helsinki, Helsinki University Central Hospital, Department of Periodontology, Helsinki, Finland; Department of Periodontology, Faculty of Odontology, Malmo University, Malmo, Sweden","Conceived and designed the experiments: NR AG AN LR B. Klinge TS B. Kjellström. Performed the experiments: TS TT. Analyzed the data: NR AG TS. Contributed reagents/materials/analysis tools: NR AG B. Klinge LR AN B. Kjellström TS. Wrote the paper: NR TS AG AN B. Kjellström TT B. Klinge.","The authors have read the journals policy and the authors of this manuscript have the following competing interests: Prof. Timo Sorsa, University of Helsinki, Finland, holds US-Patents 5736341, 5652227, 5866432 and 6143476 on/describing/addressing technology on oral fluid diagnostic MMP-8 immunoassay, and this technology has been utilized in the authors paper. The patent is owned by Oy Medixbiochemica Ab/Ltd, Kauniainen, Finland, and according to the contract between Prof. Timo Sorsa and Medix Biochemica Oy/Ab/Ltd Prof. Timo Sorsa has received royalties from the Medix-company. Prof. Timo Sorsa confirms that this does not alter adherence to all PLOS ONE polices on sharing data and materials.","2015","07","Nilminie Rathnayake","NR",9,TRUE,5,2,3,5,TRUE,TRUE,FALSE,0,NA,FALSE
